Search research articles
Contact Us
Filters
Showing results (181-190 of 244) with videos related to
Page
of 25
Sort By:
Contemporary Clinical Trials Communications
|
April 7, 2023
Aqua polo: Preliminary feasibility and efficacy study of a programme of adapted, supervised water polo to reduce fatigue and improve women's psychological and social recovery after breast cancer treatment: A mixed-methods design
S Cuvelier, C Goetgheluck-Villaron, M Cohen, et al.
Bone Marrow Transplantation
|
February 28, 2006
Post-operative sequential high-dose chemotherapy with haematopoietic stem cell support as front-line treatment in advanced ovarian cancer: a phase II multicentre study
A Gonçalves, R Delva, M Fabbro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 17, 2007
Inflammatory breast cancer in Tunisia in the era of multimodality therapy
S I Labidi, K Mrad, A Mezlini, et al.
Pathologie-Biologie
|
February 1, 1989
[Intensive chemotherapy and autograft of bone marrow in solid tumors in adults]
D Maraninchi, P Viens, A M Stoppa, et al.
Bone Marrow Transplantation
|
August 3, 2004
Mycophenolate mofetil and cyclosporine for graft-versus-host disease prophylaxis following reduced intensity conditioning allogeneic stem cell transplantation
M Mohty, H de Lavallade, C Faucher, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
March 27, 1999
Treatment of chronic myelogenous leukemia with interleukin-2: a phase II study in 21 patients
N Vey, D Blaise, M Lafage, et al.
Bone Marrow Transplantation
|
August 1, 1997
High-dose sequential chemotherapy with stem cell support for non-metastatic breast cancer
P Viens, G Gravis, D Genre, et al.
Melanoma Research
|
February 8, 2000
Results of a phase II trial with cystemustine at 90 mg/m(2) as a first- or second-line treatment in advanced malignant melanoma: a trial of the EORTC Clinical Studies Group
H Cure, P Souteyrand, R Ouabdesselam, et al.
Bulletin Du Cancer
|
July 1, 1995
[Comparison of anxiety and pain in two procedures of hematopoietic stem cell collection: cytapheresis and bone marrow collection]
G Macquart-Moulin, P Auquier, A G Le Corroller, et al.
International Journal of Cancer
|
March 17, 2000
Prognosis of breast-carcinoma lymphagenesis evaluated by immunohistochemical investigation of vascular-endothelial-growth-factor receptor 3
J Jacquemier, M P Mathoulin-Portier, R Valtola, et al.
Page
of 25
Search research articles
Search
Showing results (181-190 of 244) with videos related to
Sort By:
Page
of 25
Contemporary Clinical Trials Communications
|
April 7, 2023
Aqua polo: Preliminary feasibility and efficacy study of a programme of adapted, supervised water polo to reduce fatigue and improve women's psychological and social recovery after breast cancer treatment: A mixed-methods design
S Cuvelier, C Goetgheluck-Villaron, M Cohen, et al.
Bone Marrow Transplantation
|
February 28, 2006
Post-operative sequential high-dose chemotherapy with haematopoietic stem cell support as front-line treatment in advanced ovarian cancer: a phase II multicentre study
A Gonçalves, R Delva, M Fabbro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 17, 2007
Inflammatory breast cancer in Tunisia in the era of multimodality therapy
S I Labidi, K Mrad, A Mezlini, et al.
Pathologie-Biologie
|
February 1, 1989
[Intensive chemotherapy and autograft of bone marrow in solid tumors in adults]
D Maraninchi, P Viens, A M Stoppa, et al.
Bone Marrow Transplantation
|
August 3, 2004
Mycophenolate mofetil and cyclosporine for graft-versus-host disease prophylaxis following reduced intensity conditioning allogeneic stem cell transplantation
M Mohty, H de Lavallade, C Faucher, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
March 27, 1999
Treatment of chronic myelogenous leukemia with interleukin-2: a phase II study in 21 patients
N Vey, D Blaise, M Lafage, et al.
Bone Marrow Transplantation
|
August 1, 1997
High-dose sequential chemotherapy with stem cell support for non-metastatic breast cancer
P Viens, G Gravis, D Genre, et al.
Melanoma Research
|
February 8, 2000
Results of a phase II trial with cystemustine at 90 mg/m(2) as a first- or second-line treatment in advanced malignant melanoma: a trial of the EORTC Clinical Studies Group
H Cure, P Souteyrand, R Ouabdesselam, et al.
Bulletin Du Cancer
|
July 1, 1995
[Comparison of anxiety and pain in two procedures of hematopoietic stem cell collection: cytapheresis and bone marrow collection]
G Macquart-Moulin, P Auquier, A G Le Corroller, et al.
International Journal of Cancer
|
March 17, 2000
Prognosis of breast-carcinoma lymphagenesis evaluated by immunohistochemical investigation of vascular-endothelial-growth-factor receptor 3
J Jacquemier, M P Mathoulin-Portier, R Valtola, et al.
Page
of 25